Gliclazide

Gliclazide is a hypoglycaemic sulfonylurea antidiabetic active substance. Gliclazide reduces blood glucose levels by stimulating insulin secretion from the pancreatic beta cells and by modifying the utilisation of blood glucose in the body. The risk of hypoglycaemia must be carefully considered and monitored when Gliclazide is used in combination with sulphonylureas or insulin.